156 related articles for article (PubMed ID: 24595299)
1. Endoscope-guided interstitial intensity-modulated brachytherapy and intracavitary brachytherapy as boost radiation for primary early T stage nasopharyngeal carcinoma.
Wan XB; Jiang R; Xie FY; Qi ZY; Li AJ; Ye WJ; Hua YJ; Zhu YL; Zou X; Guo L; Mai HQ; Guo X; Hong MH; Chen MY
PLoS One; 2014; 9(3):e90048. PubMed ID: 24595299
[TBL] [Abstract][Full Text] [Related]
2. Dose escalation via brachytherapy boost for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy and combined chemotherapy.
Chao HL; Liu SC; Tsao CC; Lin KT; Lee SP; Lo CH; Huang WY; Liu MY; Jen YM; Lin CS
J Radiat Res; 2017 Sep; 58(5):654-660. PubMed ID: 28992206
[TBL] [Abstract][Full Text] [Related]
3. Nasopharyngeal intracavitary brachytherapy: the controversy of T2b disease.
Leung TW; Tung SY; Wong VY; Sze WK; Lui CM; Wong FC; Lee AS; O SK
Cancer; 2005 Oct; 104(8):1648-55. PubMed ID: 16118806
[TBL] [Abstract][Full Text] [Related]
4. High-dose-rate intracavitary brachytherapy boost for early T stage nasopharyngeal carcinoma{private}.
Leung TW; Wong VY; Sze WK; Lui CM; Tung SY
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):361-7. PubMed ID: 17892917
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional conformal radiotherapy versus intracavitary brachytherapy for salvage treatment of locally persistent nasopharyngeal carcinoma.
Zheng XK; Chen LH; Chen YQ; Deng XG
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):165-70. PubMed ID: 15337552
[TBL] [Abstract][Full Text] [Related]
6. Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dose-tumor-control relationship above conventional tumoricidal dose.
Teo PM; Leung SF; Lee WY; Zee B
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):445-58. PubMed ID: 10661353
[TBL] [Abstract][Full Text] [Related]
7. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.
Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; O SK
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):405-12. PubMed ID: 10802367
[TBL] [Abstract][Full Text] [Related]
8. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma.
Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; Wong CS; O SK
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1331-8. PubMed ID: 11121630
[TBL] [Abstract][Full Text] [Related]
9. 3D-image-guided HDR-brachytherapy versus 2D HDR - brachytherapy after external beam radiotherapy for early T-stage nasopharyngeal carcinoma.
Ren Y; Zhao Q; Liu H; Huang Y; Wang Z; Cao X; Teh BS; Wen B
BMC Cancer; 2014 Nov; 14():894. PubMed ID: 25432818
[TBL] [Abstract][Full Text] [Related]
10. [Long-term efficacy of external radiotherapy plus intracavitary hyperfractionated brachytherapy on nasopharyngeal carcinoma].
Lin SJ; Pan JJ; Wu JX; Han L; Pan CZ
Ai Zheng; 2007 Feb; 26(2):208-11. PubMed ID: 17298755
[TBL] [Abstract][Full Text] [Related]
11. Addition of intracavitary brachytherapy to external beam radiation therapy for T1-T2 nasopharyngeal carcinoma.
Wu J; Guo Q; Lu JJ; Zhang C; Zhang X; Pan J; Tham IW
Brachytherapy; 2013; 12(5):479-86. PubMed ID: 23466362
[TBL] [Abstract][Full Text] [Related]
12. Significance of boost dose for T4 nasopharyngeal carcinoma with residual primary lesion after intensity-modulated radiotherapy.
Fei Z; Xu T; Qiu X; Li M; Chen T; Li L; Huang C; Chen C
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2047-2055. PubMed ID: 33392660
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.
Lee N; Xia P; Quivey JM; Sultanem K; Poon I; Akazawa C; Akazawa P; Weinberg V; Fu KK
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):12-22. PubMed ID: 12007936
[TBL] [Abstract][Full Text] [Related]
15. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
16. Managing nasopharyngeal carcinoma with intracavitary brachytherapy: one institution's 45-year experience.
Lee N; Hoffman R; Phillips TL; Xia P; Quivey JM; Weinberg V; Hsu IC
Brachytherapy; 2002; 1(2):74-82. PubMed ID: 15062174
[TBL] [Abstract][Full Text] [Related]
17. 3D-CT implanted interstitial brachytherapy for T2b nasopharyngeal carcinoma.
Ren YF; Gao YH; Cao XP; Ye WJ; Teh BS
Radiat Oncol; 2010 Nov; 5():113. PubMed ID: 21092297
[TBL] [Abstract][Full Text] [Related]
18. Image-guided interstitial brachytherapy boost for nasopharyngeal carcinoma: technical aspects.
Murakami N; Cheng G; Yoshimoto S; Itami J
J Contemp Brachytherapy; 2020 Jun; 12(3):294-302. PubMed ID: 32695204
[TBL] [Abstract][Full Text] [Related]
19. The role of brachytherapy in early-stage nasopharyngeal carcinoma.
Chang JT; See LC; Tang SG; Lee SP; Wang CC; Hong JH
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1019-24. PubMed ID: 8985022
[TBL] [Abstract][Full Text] [Related]
20. Improved local control for early T-stage nasopharyngeal carcinoma--a tale of two hospitals.
Teo PM; Leung SF; Fowler J; Leung TW; Tung Y; O SK; Lee WY; Zee B
Radiother Oncol; 2000 Nov; 57(2):155-66. PubMed ID: 11054519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
